{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:59:06Z","timestamp":1761310746413},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.biologicals.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T03:47:21Z","timestamp":1324439241000},"page":"15-20","source":"Crossref","is-referenced-by-count":4,"title":["Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies"],"prefix":"10.1016","volume":"40","author":[{"given":"Girish N.","family":"Vyas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Stoddart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Scott","family":"Killian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd V.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Ziman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Bryson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2011.11.005_bib1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1377\/hlthaff.28.6.1629","article-title":"Investing to meet the scientific challenges of HIV\/AIDS","volume":"28","author":"Fauci","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.biologicals.2011.11.005_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2010.09.011","article-title":"Induction of immunity to human immunodeficiency virus type-1 by vaccination","volume":"33","author":"McElrath","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biologicals.2011.11.005_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1126\/science.6264599","article-title":"Biology of hepatitis B virus","volume":"213","author":"Tiollais","year":"1981","journal-title":"Science"},{"issue":"67","key":"10.1016\/j.biologicals.2011.11.005_bib5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.178.4067.1300","article-title":"Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds","volume":"178","author":"Vyas","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2011.11.005_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4049\/jimmunol.108.4.1114","article-title":"Hepatitis-associated Australia antigen. Protein, peptides and amino acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test","volume":"108","author":"Vyas","year":"1972","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.124.4.1589","article-title":"49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles","volume":"124","author":"Mishiro","year":"1980","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/606119","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose","volume":"200","author":"McMahon","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2011.11.005_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"Liu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2011.11.005_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biologicals.2011.11.005_bib11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission","volume":"303","author":"Derdeyn","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2011.11.005_bib12","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biologicals.2011.11.005_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20090378","article-title":"Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection","volume":"206","author":"Salazar-Gonzalez","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biologicals.2011.11.005_bib14","first-page":"345","article-title":"Human peripheral blood mononuclear cell substrate for propagating wild type HIV-1","volume":"106","author":"Vyas","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.biologicals.2011.11.005_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1537-2995.2010.02831.x","article-title":"Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection","volume":"51","author":"Lai-Hipp","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2011.11.005_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biologicals.2007.04.002","article-title":"A\u00a0hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate","volume":"35","author":"Leong","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.11.005_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-170-3_2","article-title":"Purification of HIV-1 virions by subtilisin digestion or CD45 immunoaffinity depletion for biochemical studies","volume":"485","author":"Ott","year":"2009","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.biologicals.2011.11.005_bib18","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1128\/JVI.77.15.8237-8248.2003","article-title":"Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts","volume":"77","author":"Graham","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib19","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1371\/journal.pone.0000655","article-title":"Validation of the SCID-hu Thy\/Liv mouse model with four classes of licensed antiretrovirals","volume":"2","author":"Stoddart","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2011.11.005_bib20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.176.4.1203","article-title":"Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response","volume":"176","author":"Chan","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biologicals.2011.11.005_bib21","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1128\/JVI.76.11.5667-5677.2002","article-title":"Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication","volume":"76","author":"Forshey","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib22","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1021\/bi800540b","article-title":"Virus-like particles as quantitative probes of membrane protein interactions","volume":"47","author":"Willis","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.biologicals.2011.11.005_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1189\/jlb.71.6.921","article-title":"DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology","volume":"71","author":"Geijtenbeek","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib24","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1128\/JVI.79.8.4589-4598.2005","article-title":"Characterization of DC-SIGN\/R interaction with human immunodeficiency virus type-1 gp120 and ICAM molecules favors the receptor\u2019s role as an antigen-capturing rather than an adhesion receptor","volume":"79","author":"Snyder","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2011.11.005_bib26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.86.5.1624","article-title":"Generation of human monoclonal antibodies to human immunodeficiency virus","volume":"86","author":"Gorny","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2011.11.005_bib27","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","author":"Tyler","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib28","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.65.9.4832-4838.1991","article-title":"Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies","volume":"65","author":"Xu","year":"1991","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib29","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4049\/jimmunol.138.10.3415","article-title":"Differential ability of human immunodeficiency virus isolates to productively infect human cells","volume":"138","author":"Evans","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib30","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/aid.1996.12.1341","article-title":"Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees","volume":"12","author":"Murthy","year":"1996","journal-title":"AIDS ResHumRetroviruses"},{"key":"10.1016\/j.biologicals.2011.11.005_bib31","doi-asserted-by":"crossref","first-page":"51828","DOI":"10.1074\/jbc.M402741200","article-title":"Proteomic analysis of DC-sign on dentritic cells detects tetramers required for ligand binding but no association with CD4","volume":"279","author":"Bernhard","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.biologicals.2011.11.005_bib32","doi-asserted-by":"crossref","first-page":"e8297","DOI":"10.1371\/journal.pone.0008297","article-title":"Human Erythrocytes Selectively bind and enrich infectious HIV-1 virions","volume":"4","author":"Beck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biologicals.2011.11.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199107043250101","article-title":"Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells","volume":"325","author":"Busch","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2011.11.005_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2011.11.005_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2011.11.005_bib36","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2011.11.005_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 subunit virosomes Induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges","volume":"34","author":"Bomsel","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.biologicals.2011.11.005_bib38","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:23:15Z","timestamp":1686529395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105611001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1045105611001916"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2011.11.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}